Lower respiratory tract infection
Pro Research Analysisby 
Searched over 200M research papers
Lower Respiratory Tract Infection: Definition and Epidemiology
Lower respiratory tract infections (LRTIs) include bronchitis, bronchiolitis, and pneumonia, and are a leading cause of death and illness worldwide, especially in adults and hospitalized patients 1458. LRTIs are less common than upper respiratory tract infections but cause more severe illness and higher morbidity 28. Pneumonia, in particular, is the fourth leading cause of death globally 48.
Common Pathogens in Lower Respiratory Tract Infections
Bacterial Causes
The most frequent bacterial pathogens in LRTIs are Streptococcus pneumoniae and Haemophilus influenzae, with other important bacteria including Mycoplasma pneumoniae, Staphylococcus aureus, various gram-negative bacilli, and Legionella species 3479. In community-acquired pneumonia, gram-negative organisms and staphylococci are responsible for about one-third of cases, while nosocomial (hospital-acquired) pneumonia is even more often caused by gram-negative bacteria 14. Mixed bacterial and viral infections are also common, occurring in about 10% of cases .
Viral Causes
Viruses are detected in nearly half of adult LRTI cases in primary care, with human rhinovirus, influenza viruses, respiratory syncytial virus (RSV), coronavirus, and human metapneumovirus being the most common 3910. Viral LRTIs can cause symptoms and illness severity similar to those caused by influenza, and RSV and hMPV infections are associated with longer symptom duration .
Other and Emerging Pathogens
Other notable pathogens include Chlamydia pneumoniae, Moraxella catarrhalis, and, in immunocompromised patients, Mycobacterium tuberculosis and Pneumocystis jirovecii 236. The discovery of new pathogens, such as Legionella and novel viruses, continues to change the landscape of LRTI etiology 23.
Risk Factors and Special Populations
LRTIs are particularly severe in immunocompromised individuals, such as those with HIV/AIDS or those receiving immunosuppressive therapies 26. Changes in population demographics, smoking prevalence, and vaccine use (such as the pneumococcal conjugate vaccine) also influence the epidemiology and frequency of LRTIs .
Diagnosis and Clinical Management
Diagnosing the specific cause of LRTI can be challenging, as clinical features often overlap and laboratory confirmation is not always possible 47. Sputum Gram stain, blood cultures, and molecular tests can help identify pathogens, but many cases remain undiagnosed 49.
Antibiotic resistance is a growing concern, especially among Streptococcus pneumoniae, Haemophilus influenzae, and Mycobacterium tuberculosis 2479. However, penicillin-resistant pneumococci and β-lactamase-producing H. influenzae remain relatively uncommon in primary care . Guidelines recommend a restrictive approach to antibiotic use, favoring narrow-spectrum agents when antibiotics are needed 79.
Pathogenesis and Immune Response
The severity of LRTIs is influenced by the interaction between the infecting pathogen and the host's immune response. Inflammation and the innate immune system play key roles in both clearing infections and contributing to lung damage if the response is excessive . Some LRTIs can lead to long-term complications, such as bronchiectasis, lung fibrosis, and decreased lung function .
Conclusion
Lower respiratory tract infections are a major global health concern, causing significant illness and death, especially in vulnerable populations. Both bacteria and viruses are important causes, with mixed infections being common. Diagnosis can be difficult, and antibiotic resistance is an ongoing challenge. Effective management relies on careful clinical assessment, judicious use of antibiotics, and attention to changing epidemiological trends 1234+6 MORE.
Sources and full results
Most relevant research papers on this topic